1. Synthesis, Characterization and Antimicrobial Activity of Trimethylantimony(V) Biscyanoximates, a New Family of Antimicrobials.
- Author
-
Amankrah SA, Salpadoru T, Cotton K, Patrauchan MA, Wozniak KL, and Gerasimchuk N
- Subjects
- Antimony chemistry, Antimony pharmacology, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents chemistry, Anti-Bacterial Agents chemical synthesis, Antifungal Agents pharmacology, Antifungal Agents chemical synthesis, Antifungal Agents chemistry, Oximes chemistry, Oximes pharmacology, Oximes chemical synthesis, Molecular Structure, Bacteria drug effects, Structure-Activity Relationship, Candida albicans drug effects, Crystallography, X-Ray, Microbial Sensitivity Tests, Anti-Infective Agents pharmacology, Anti-Infective Agents chemistry, Anti-Infective Agents chemical synthesis
- Abstract
Antimicrobial compounds play a critical role in combating microbial infections. However, the emergence of antibiotic and antifungal resistance and the scarcity of new antibiotic developments pose a significant threat and demand the discovery of new antimicrobials for both bacterial and fungal pathogens. Our previous work described the first generation ( G1 ) of organoantimony-based compounds that showed antimicrobial activity against several bacterial and fungal pathogens. Here, we present our efforts in modifying these compounds by replacing the tetraphenyl backbone in G1 compounds with a trimethyl group, thereby generating a new series of compounds we refer to as "generation 2", G2 . In addition to the novel backbone structure, we introduced three new anionic chloro-cyanoxime ligand groups, namely 2,4-diCl-PhCO
- , 2,6-diCl-PhCO- and 2Cl-PhCO- , which were found to be biologically active in the past. Nine new compounds of SbMe3 L2 composition were obtained in high yields and characterized by NMR, IR spectroscopies, thermogravimetric TG/DSC and X-ray single crystal analyses. The antibacterial activity of the cyanoximates was tested against three bacterial ( Pseudomonas aeruginosa PAO1, Escherichia coli S17 and methicillin-resistant Staphylococcus aureus (MRSA) NRS70) and two fungal ( Candida albicans strain SC5314 and Cryptococcus neoformans strain H99) pathogens. Two compounds, SbMe3 (MCO)2 and SbMe3 (2,4-diClPhCO)2 , were active against bacterial strains and inhibited the growth of PAO1 and MRSA with MICs of 50 and 100 µg/mL, respectively. Three compounds, SbMe3 (MCO)2 , SbMe3 (ECO)2 and SbMe3 (TCO)2 , were active against fungal strains and inhibited either one of or both C. albicans and C. neoformans at MICs of 2.6-66.67 μg/mL. In addition, SbMe3 (TCO)2 and SbMe3 (MCO)2 were fungicidal at MFC 33.33-66.67 μg/mL. Ultra-thin-layer TEM imaging suggested that SbMe3 (MCO)2 targets the integrity of bacterial membranes. Overall, four of the studied G2 series compounds possess antimicrobial activity against a broad range of microbial pathogens, with particular potential against fungal pathogens, which will be explored in further studies.- Published
- 2024
- Full Text
- View/download PDF